Nicole Kasten

Washington University in St. Louis

Papers

1

Total Citations

19

H-Index

1

About

Dr. Nicole Kasten is a leading oncologic surgeon whose work focuses on the intersection of immunotherapy and surgical management for advanced kidney cancers. Her most impactful research addresses a critical clinical challenge: treating patients with initially unresectable metastatic clear cell renal cell carcinoma. In her landmark 2020 study, Dr. Kasten demonstrated that elective cytoreductive nephrectomy can be safely and effectively performed after checkpoint inhibitor immunotherapy, offering a new, potentially life-extending pathway for patients previously deemed inoperable. This work, which has garnered 19 citations, has helped reshape surgical paradigms in the era of modern immunotherapy. Beyond this pivotal contribution, Dr. Kasten’s broader research portfolio explores how to optimize multimodal treatment sequences, combining targeted therapies and immune checkpoint blockade with surgical intervention to improve outcomes in genitourinary malignancies. Her clinical expertise and rigorous approach to studying complex, high-risk patient populations have established her as an emerging authority in urologic oncology, bridging the gap between medical and surgical oncology to advance personalized, curative-intent strategies for patients with advanced kidney cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma
19 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Washington University in St. Louis

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago